Physician profile
Tyler G Smith
NPI 1386650802
$1,042,915.16
in general payments reported to CMS, 2019-2025
26 companies · $391K in 2025
The $391K reported for 2025 was more than what 98% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136K · 2020: $71K · 2021: $114K · 2022: $94K · 2023: $125K · 2024: $113K · 2025: $391K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $465K · Consulting Fee: $146K · Travel and Lodging: $12K · Food and Beverage: $5,745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $464,970.59 |
| Consulting Fee | $145,625.71 |
| Travel and Lodging | $12,189.53 |
| Food and Beverage | $5,744.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $839,106.36 | 2019-2025 | Other - Miscellaneous, Safeop, Identiti |
| Nuvasive, INC. | $161,880.94 | 2019-2023 | Coroent |
| Globus Medical, INC. | $30,775.24 | 2024-2025 | Autobahn, Coroent, Excelsius Gps |
| Si-Bone, INC. | $5,775.87 | 2019-2025 | |
| Augmedics INC. | $2,845.32 | 2022-2025 | Xvision |
| Providence Medical Technology, INC. | $693.34 | 2019-2025 | |
| Intrinsic Therapeutics | $335.37 | 2021-2025 | Barricaid Acd (Annular Closure Device) |
| Stryker Corporation | $277.80 | 2019-2021 | |
| Zimvie INC. | $186.00 | 2022-2023 | |
| Zimmer Biomet Holdings, INC. | $148.18 | 2019-2021 | |
| Medtronic, INC. | $118.99 | 2023 | Intellis Adaptivestim |
| Encore Medical, Lp | $116.00 | 2022 | |
| Centinel Spine, LLC | $113.75 | 2019-2024 | Prodisc C Vivo |
| Depuy Synthes Sales INC. | $91.62 | 2021-2024 | Na |
| Kahtnu Surgical, INC. | $80.99 | 2020-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $71.23 | 2019 | |
| Wenzel Spine, INC. | $64.35 | 2022 | |
| Kerecis Limited | $40.25 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Spineology INC. | $33.63 | 2020 | |
| Z-Medica, LLC | $29.23 | 2019 | |
| Glaxosmithkline, LLC. | $27.33 | 2024 | Trelegy Ellipta |
| Boston Scientific Corporation | $26.17 | 2025 | Wavewriter Alpha Prime 16 |
| Nevro Corp. | $24.09 | 2019 | |
| Evolution Surgical, INC | $22.66 | 2025 | |
| Painteq LLC | $17.53 | 2021 | |
| Philips North America LLC | $12.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.